Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
Sponsor: Centre Hospitalier Henri Laborit
Summary
The aim of the study is to demonstrate a significant improvement in quality of life specific to patients with fibromyalgia syndrome in patients with fibromyalgia syndrome with comorbid posttraumatic stress disorder, treated with reconsolidation blockade. Patients receive a treatment with propranolol associated with reconsolidation blockade of traumatic story once a week during 6 weeks, with evaluation at inclusion and at 3 months.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
17
Start Date
2021-08-13
Completion Date
2025-01-13
Last Updated
2026-09-09
Healthy Volunteers
No
Interventions
Propranolol
One administration of propranolol, once a week during six weeks. Reading by the participant of his/her traumatic story, 75 minutes (+/- 15 min) after propranolol intake.
Locations (2)
Centre Hospitalier Henri Laborit
Poitiers, France
Centre Hospitalier Nord-Deux-Sèvres
Thouars, France